The p53/IGF-1 receptor axis in the regulation of programmed cell death.
The loss or functional inactivation of tumor suppressor genes appears to be one of the most fundamental genetic mechanisms of tumorigenesis, and rational insights into the signaling pathways of tumor suppressor genes have emerged as a successful strategy of identifying novel drug discovery targets downstream of the tumor suppressor protein itself. Elucidation of novel pathways downstream of p53 have established a link between this important tumor suppressor gene and the insulin-like growth factor-1 receptor (IGF-1r), either via direct regulation of IGF-1 receptor levels, or modulation of IGFs via transactivation of the insulin-like growth factor-binding protein 3 (IGF-BP3) gene. Binding of IGF-BP3 to IGFs inhibits both their mitogenic and cell survival functions, highlighting a novel pathway whereby p53 may regulate apoptosis in tumor cells.
Neuberg
M
M
Department of Molecular Genetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA.
Buckbinder
L
L
Seizinger
B
B
Kley
N
N
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D016158:Genes, p53 / Q000235:genetics / Q000502:physiology*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000502:physiology*
D018972:Insulin-Like Growth Factor Binding Protein 3; D017526:Receptor, IGF Type 1